Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BTN1A1P1 is a genomically-encoded pseudogene related to butyrophilin subfamily 1 member A1 (BTN1A1), which does not produce a functional protein and has no established biological or pharmacological role. It is annotated in major gene databases as a pseudogene and should not be confused with BTN1A1, the protein-coding gene involved in milk-fat droplet secretion and potential immune signaling. Pseudogenes like BTN1A1P1 may occasionally have regulatory roles at the RNA level in some contexts, but there is no scientific literature establishing any function for BTN1A1P1 specifically[2][5][6][10]. If you are interested in the functional protein which is a possible receptor and has a role in milk secretion and immunity, you should refer to Butyrophilin subfamily 1 member A1 (BTN1A1), not BTN1A1P1[1][3][4]. BTN1A1P1 is not a therapeutic target and not functionally equivalent to BTN1A1.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Butyrophilin subfamily 1 member A1 pseudogene 1 (BTN1A1P1).